Abuhejleh Hasan, Wunder Jay S, Ferguson Peter C, Isler Marc H, Mottard Sophie, Werier Joel A, Griffin Anthony M, Turcotte Robert E
McGill University Health Centre, Montreal, QC, Canada.
Mount Sinai Hospital, Toronto, ON, Canada.
Eur J Orthop Surg Traumatol. 2020 Jan;30(1):11-17. doi: 10.1007/s00590-019-02496-2. Epub 2019 Jul 11.
Distal radius giant cell tumour (GCT) is known to be associated with distinct management difficulties, including high rates of local recurrence and lung metastases compared to other anatomic locations. Multiple treatment options exist, each with different outcomes and complications.
QUESTIONS/PURPOSES: To compare oncological and functional outcomes and complications following treatment of patients with distal radius GCT by extended intralesional curettage (EIC) or resection-arthrodesis.
Patients operated on for distal radius GCT were identified from prospectively collected databases at four Canadian musculoskeletal oncology specialty centres. There were 57 patients with a mean age of 35.4 years (range 17-57). Thirteen tumours were Campanacci grade 2, and 40 were Grade 3 (4 unknown). Twenty patients presented with an associated pathologic fracture. There were 34 patients treated by EIC and 23 by en bloc resection and wrist arthrodesis. All resections were performed for grade 3 tumours. The mean follow-up was 86 months (range 1-280).
There were a total of 11 (19%) local recurrences: 10 of 34 (29%) in the EIC group compared to only 1 of 23 (4%) in the resection-arthrodesis group (p = 0.028). For the 10 patients with local recurrence following initial treatment by EIC, 7 underwent repeat EIC, while 3 required resection-arthrodesis. The one local recurrence following initial resection was managed with repeat resection-arthrodesis. Six of the 11 local recurrences followed treatment of Campanacci grade 3 tumours, while 4 were in grade 2 lesions and in one case of recurrence the grade was unknown. There were no post-operative complications after EIC, whereas 7 patients (30%) had post-operative complications following resection-arthrodesis including 4 infections, one malunion, one non-union and one fracture (p = 0.001). The mean post-operative Musculoskeletal Tumor Society score was 33.5 in the curettage group compared to 27 in the resection group (p = 0.001). The mean Toronto Extremity Salvage Score was 98.3% following curettage compared to 91.5% after resection (p = 0.006). No patients experienced lung metastasis or death.
EIC is an effective alternative to wide resection-arthrodesis following treatment of distal radius GCT, with the advantage of preserving the distal radius and wrist joint function, but with a higher risk of local recurrence. Most local recurrences following initial treatment by EIC could be managed with iterative curettage and joint preservation. Wide excision and arthrodesis were associated with a significantly lower risk of tumour recurrence but was technically challenging and associated with more frequent post-operative complications. EIC was associated with better functional scores. Resection should be reserved for the most severe grade 3 tumours and recurrent and complex cases not amenable to treatment with EIC and joint salvage.
III, retrospective comparative trial.
已知桡骨远端骨巨细胞瘤(GCT)在治疗上存在独特的困难,与其他解剖部位相比,其局部复发率和肺转移率较高。目前有多种治疗选择,每种治疗方法的疗效和并发症各不相同。
问题/目的:比较采用扩大刮除术(EIC)或切除融合术治疗桡骨远端GCT患者后的肿瘤学和功能结局以及并发症。
从加拿大四个肌肉骨骼肿瘤专科中心前瞻性收集的数据库中,确定接受桡骨远端GCT手术的患者。共有57例患者,平均年龄35.4岁(范围17 - 57岁)。13例肿瘤为Campanacci 2级,40例为3级(4例分级未知)。20例患者伴有病理性骨折。34例患者接受了EIC治疗,23例接受了整块切除及腕关节融合术。所有切除术均针对3级肿瘤进行。平均随访时间为86个月(范围1 - 280个月)。
共有11例(19%)局部复发:EIC组34例中有10例(29%)复发,而切除融合术组23例中仅1例(4%)复发(p = 0.028)。对于最初接受EIC治疗后局部复发的10例患者,7例接受了再次EIC治疗,3例需要进行切除融合术。初次切除术后的1例局部复发通过再次切除融合术处理。11例局部复发中有6例发生在Campanacci 3级肿瘤治疗后,4例发生在2级病变中,1例复发患者的分级未知。EIC术后无术后并发症,而切除融合术后有7例患者(30%)出现术后并发症,包括4例感染、1例骨愈合不良、1例骨不连和1例骨折(p = 0.001)。刮除术组术后肌肉骨骼肿瘤学会平均评分为33.5分,而切除组为27分(p = 0.001)。刮除术后多伦多肢体挽救评分平均为98.3%,切除术后为91.5%(p = 0.006)。无患者发生肺转移或死亡。
EIC是桡骨远端GCT治疗后广泛切除融合术的有效替代方法,具有保留桡骨远端和腕关节功能的优点,但局部复发风险较高。初次接受EIC治疗后的大多数局部复发可以通过反复刮除和保留关节来处理。广泛切除和融合术与肿瘤复发风险显著降低相关,但技术上具有挑战性且术后并发症更常见。EIC与更好的功能评分相关。切除术应保留用于最严重的3级肿瘤以及不适用于EIC和保留关节治疗的复发和复杂病例。
III级,回顾性比较试验。